- Location
Maestro system
"-
Enteromedics Submitted Pma Application to US FDA for Maestro Rechargeable System's VBLOC
Jul 30, 2013EnteroMedics has submitted premarket approval (PMA) application to the US Food and Drug Administration (FDA) for Maestro Rechargeable System's VBLOC, a vagal blocking therapy to treat obesity. Maestro RC system delivers vagal blocking ...
Tags: EnteroMedics, Vbloc Therapy
-
EnteroMedics Is Planning to Submit PMA for VBLOC Therapy in Second Quarter of 2013
May 22, 2013EnteroMedics is planning to submit the pre-PMA (Premarket Approval) application for its Maestro Rechargeable System's VBLOC vagal blocking therapy, based on the ReCharge Pivotal Trial, in the second quarter of 2013. The decision follows ...
Tags: Enteromedics, VBLOC Therapy
-
Vagal Blocking Therapy Is The Reason of Enteromedics Announces Study
Feb 18, 2013EnteroMedics has reported ReCharge study results of its VBLOC vagal blocking therapy, designed for the treatment of obesity. The pacemaker-like Maestro system delivers VBLOC therapy via two small electrodes that are laparoscopically ...
-
Enteromedics Has Reported Subgroup Analysis Data From EMPOWER
Dec 17, 2012EnteroMedics has reported subgroup analysis data from EMPOWER trial of its pacemaker-like device, designed to target the multiple digestive functions under control of the vagus nerves and to affect the perception of hunger and fullness. ...
Tags: EnteroMedics, VBLOC, Maestro system
-
EnteroMedics Has Implanted The Maestro Rechargeable System at The Hadi Hospital in Kuwait
Dec 14, 2012EnteroMedics has, for the first time, implanted the Maestro Rechargeable system at the Hadi Hospital in Kuwait. Maestro system featuring two small electrodes are laparoscopically implanted and placed in contact with the trunks of the ...
Tags: EnteroMedics, Maestro Rechargeable system, small electrodes
